Dimensional analysis of MINMOD leads to definition of the disposition index of glucose regulation and improved simulation algorithm

Biomed Eng Online. 2006 Jul 14:5:44. doi: 10.1186/1475-925X-5-44.

Abstract

Background: Frequently Sampled Intravenous Glucose Tolerance Test (FSIVGTT) together with its mathematical model, the minimal model (MINMOD), have become important clinical tools to evaluate the metabolic control of glucose in humans. Dimensional analysis of the model is up to now not available.

Methods: A formal dimensional analysis of MINMOD was carried out and the degree of freedom of MINMOD was examined. Through re-expressing all state variable and parameters in terms of their reference scales, MINMOD was transformed into a dimensionless format. Previously defined physiological indices including insulin sensitivity, glucose effectiveness, and first and second phase insulin responses were re-examined in this new formulation. Further, the parameter estimation from FSIVGTT was implemented using both the dimensional and the dimensionless formulations of MINMOD, and the performances were compared utilizing Monte Carlo simulation as well as real human FSIVGTT data.

Results: The degree of freedom (DOF) of MINMOD was found to be 7. The model was maximally simplified in the dimensionless formulation that normalizes the variation in glucose and insulin during FSIVGTT. In the new formulation, the disposition index (Dl), a composite parameter known to be important in diabetes pathology, was naturally defined as one of the dimensionless parameters in the system. The numerical simulation using the dimensionless formulation led to a 1.5-5 fold gain in speed, and significantly improved accuracy and robustness in parameter estimation compared to the dimensional implementation.

Conclusion: Dimensional analysis of MINMOD led to simplification of the model, direct identification of the important composite factors in the dynamics of glucose metabolic control, and better simulations algorithms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms*
  • Blood Glucose / analysis*
  • Blood Glucose / metabolism*
  • Computer Simulation
  • Diagnosis, Computer-Assisted / methods*
  • Feedback / physiology
  • Glucose Tolerance Test / methods*
  • Homeostasis / physiology
  • Humans
  • Insulin / blood*
  • Models, Biological*
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Blood Glucose
  • Insulin